Cullinan Therapeutics, Inc. (NASDAQ:CGEM) IPO
IPO
Went public as Cullinan Management, Inc. Priced at US$21.00 a share on Jan 7, 2021.
- Price
- US$21.00 a share
- Shares offered
- 11,900,000 shares of common stock
- Offering size
- US$249.9 million
- Underwriters' option
- Up to 1,785,000 more shares
- Underwriters
- MORGAN STANLEY, SVB LEERINK, EVERCORE ISI, H.C. WAINWRIGHT & CO. · In the order on the cover
- Shares delivered
- On or about Jan 12, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 2, 2020 |
| Filed publicly | Dec 18, 2020 |
| Amended 3 times | Newest Jan 6, 2021 |
| Shares registered with an exchange | Jan 6, 2021 |
| Declared effective by the SEC | Jan 7, 2021 |
| Final prospectus, with the price | Jan 11, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 11, 2021 |
| EFFECT · Notice that a registration is effective | Jan 7, 2021 |
| S-1MEF · Registration of more shares for the same offering | Jan 7, 2021 |
| CERT · Exchange's certificate of listing | Jan 7, 2021 |
| CORRESP · Letter to the SEC | Jan 6, 2021 |
| S-1/A · Registration statement, amended | Jan 6, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 6, 2021 |
| UPLOAD · Letter from the SEC | Jan 5, 2021 |
| CORRESP · Letter to the SEC | Jan 4, 2021 |
| CORRESP · Letter to the SEC | Jan 4, 2021 |
| S-1/A · Registration statement, amended | Jan 4, 2021 |
| S-1/A · Registration statement, amended | Dec 28, 2020 |
| CORRESP · Letter to the SEC | Dec 18, 2020 |
| CORRESP · Letter to the SEC | Dec 18, 2020 |
| S-1 · Registration statement | Dec 18, 2020 |
| UPLOAD · Letter from the SEC | Dec 18, 2020 |
| DRSLTR · Letter to the SEC with a draft | Dec 9, 2020 |
| DRS/A · Draft registration statement, amended | Dec 9, 2020 |
| UPLOAD · Letter from the SEC | Dec 1, 2020 |
| DRS · Draft registration statement | Nov 2, 2020 |
From the cover of the final prospectus (424B4) filed Jan 11, 2021